Spinol Medical™ Advances OctaSeal™ Into FDA Review — A Minimally Invasive, Intradiscal Annular Closure Technology Backed by Five-Year Clinical Data
Spinol Medical™ today announced the advancement of its OctaSeal™ Annular Closure System into U.S. FDA review. OctaSeal represents a novel, tubular-based, intradiscal technology designed to close annular defects following lumbar discectomy. Delivered through a 5mm minimally invasive working channel, the implant expands within the disc space to create a stable, tissue-preserving, motion preserving repair.
